Home/Filings/4/0001209191-15-002191
4//SEC Filing

Anacor Pharmaceuticals, Inc. 4

Accession 0001209191-15-002191

CIK 0001411158operating

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:25 PM ET

Size

5.0 KB

Accession

0001209191-15-002191

Insider Transaction Report

Form 4
Period: 2015-01-02
Maples Kirk R
Senior VP Program Mgt
Transactions
  • Sale

    Common Stock

    2015-01-02$31.96/sh600$19,1744,200 total
Footnotes (2)
  • [F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $31.69 to $32.53, inclusive.

Issuer

Anacor Pharmaceuticals, Inc.

CIK 0001411158

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001411158

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:25 PM ET
Size
5.0 KB